Tenon Medical Inc TNON.OQ TNON.O is expected to show a rise in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025
The Los Gatos California-based company is expected to report a 66.7% increase in revenue to $1.199 million from $719 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Tenon Medical Inc is for a loss of $1.11 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Tenon Medical Inc is $3.00, above its last closing price of $1.11.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -2.54 | -2.54 | Met | 0 | |
Sep. 30 2024 | -4.05 | -4.23 | -3.63 | Beat | 14.3 |
Jun. 30 2024 | -8.72 | -8.68 | -8.16 | Beat | 6 |
Mar. 31 2024 | -10.72 | -10.72 | -10.00 | Beat | 6.7 |
Dec. 31 2023 | -11.04 | -11.04 | -5.44 | Beat | 50.7 |
Sep. 30 2023 | -21.90 | -22.40 | -11.68 | Beat | 47.9 |
Jun. 30 2023 | -30.40 | -30.40 | -26.40 | Beat | 13.2 |
Mar. 31 2023 | -29.60 | -34.40 | Missed | -16.2 |
This summary was machine generated May 9 at 21:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。